High materiality8/10
Definium Therapeutics price target raised to $75 from $70 at Oppenheimer
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer raises Definium Therapeutics (DFTX) price target to $75 from $70; current price around $40.25.
- Oppenheimer raises DFTX target to $75; price $40.25
Key facts
- 01
Target: $75
- 02
Posted price: $40.25
- 03
Analyst firm: Oppenheimer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.